Deep Tech Startups

Carbo Energy builds hybrid non-aqueous redox flow batteries for grid-scale energy storage, designed to complement renewable energy sources with a 40-year lifespan, zero fire risk, and degradation of 0.2% annually. The company serves utilities, datacenters, mining operations, and renewable energy farms across multiple markets including energy trading, backup power, and off-grid operations.

1 investor

Carbon Cell is a team of designers, engineers, and scientists developing sustainable materials aimed at reducing plastic use and carbon emissions. The company operates in the sustainable materials and climate space.

1 investor

Carbon Clean Energy develops carbon conversion technology that transforms CO2 into chemicals, materials, and fuels using an artificial photosynthesis approach powered by renewable energy. The company serves industrial manufacturers and enterprises seeking decarbonization solutions and carbon-neutral product alternatives.

1 investor

Carbonext produces high-quality 3D graphene using a scalable chemical process that substitutes graphite with biomass and industrial waste materials. The company targets commercial applications by reducing graphene production costs and enabling bulk supply at scale.

1 investor

Carocell Bio develops peptide-based anti-inflammatory therapeutics, including its lead peptide JEL0305, that inhibit the intracellular MAPK (p38) inflammatory pathway and are combined with a nanoparticle delivery technology for topical application to the skin. It targets inflammatory conditions such as eczema (atopic dermatitis) and inflammation-related skin ageing.

1 investor

Carroucell develops microcarrier technology for cell and gene therapy applications, enabling cost-effective bioproduction and cell amplification. The company serves the healthcare and biomanufacturing industries with sol-gel based microcarrier solutions.

1 investor

Carterra develops surface plasmon resonance (SPR) platforms for high-throughput biomolecular interaction analysis. The systems are designed for drug discovery, antibody development, and screening applications in research and biotech organizations.

1 investor

Carus Bio develops next-generation in vivo CAR-T therapeutics using an mRNA delivery platform technology for cell and gene therapy. The company focuses on treatments for patients in the biotech and cell-gene therapy field.

1 investor

Cascade Geomatics provides hardware and software for geotechnical monitoring, offering early warning systems for mining pit walls, benches, and haul roads, as well as always-on corridor monitoring for slopes and rail track. Its products serve mining and infrastructure operators managing ground-stability risks.

1 investor

Cassidy Bio develops a genomic foundation model that accelerates CRISPR gene editing therapy design by predicting optimal guides, editors, and delivery approaches. The platform enables therapeutic teams to move from multi-year trial-and-error to weeks of computational validation, shortening development timelines for life-saving genome editing medicines.

1 investor

CAST develops film piezoelectric sensors that are heat-resistant, flexible, and thin, used as measurement systems for industrial monitoring. Its products include a pipe wall thinning monitoring system for detecting structural degradation.

1 investor

Catalera develops biopesticide solutions using patented formulation technology for biological active ingredients. The company offers fungicides, insecticides, and miticides registered for use across consumer, professional, and agricultural applications in the United States.

1 investor

CatAmmon develops nano-ceramic catalysts intended to replace scarce platinum-group metals (PGMs) in applications such as automotive catalytic converters and ammonia cracking for hydrogen production. The company targets emission control systems and alternative energy markets with lower-cost, scalable advanced materials.

1 investor

Category Labs builds high-performance decentralized systems, including Monad, a fully EVM-compatible layer 1 blockchain designed for high throughput, fast block times, single-slot finality, and low hardware requirements. Its team draws on backgrounds in high-frequency trading and low-level systems engineering.

1 investor

CatSci is a contract research and development partner for medicines development, uniting chemistry, bioscience, analytical science, and solid-state development into integrated process development and route optimisation services. It serves large pharma, biotech, and academia clients across drug modalities, operating from sites in the UK and Europe.

1 investor

Causeway Sensors makes a compact device that measures IgG concentration directly from bioreactor samples, providing at-line, real-time data for bioproduction processes. It serves bioprocessing and biomanufacturing teams.

1 investor

Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers. Its lead product, novoleucel, is a minimally invasive cell therapy designed to improve clinical outcomes and survival for late-stage cancer patients.

1 investor

Cebina is an early-stage biotech investor and incubator that funds and de-risks pre-company and startup drug development projects across pre-seed, seed, and Series A stages. It focuses on therapeutic areas including cardiovascular and metabolic diseases, lung fibrosis, cancer immunotherapy, and anti-infectives, and also pursues co-development and licensing partnerships.</parameter> <parameter name="founders">[]

1 investor

Cedana provides infrastructure software that automatically checkpoints, migrates, and resumes live GPU jobs across computing instances to improve throughput, reliability, and performance.

1 investor

CedarDB builds high-performance database systems designed for modern hardware such as multicore processors, memory, and fast storage. Spun off from the Technical University of Munich's Umbra research project in 2024, the company develops database technology for demanding data workloads.

1 investor

Celera Technologies designs custom analog integrated circuit (IC) solutions, using AI-accelerated workflows to replace legacy analog design flows and shorten delivery times. It serves chip and hardware developers seeking custom analog silicon.

1 investor

Celero Communications develops coherent DSP (digital signal processor) technology for high-bandwidth, low-power optical connections used in AI and data center infrastructure. Its platform provides scalable optical links between AI accelerators, servers, and clusters for accelerated computing.

1 investor

Celero Systems is developing an ingestible pill-based platform that monitors cardiac and respiratory vital signs and delivers medication, aiming to monitor, diagnose, and treat life-threatening conditions without wearables or wires. It operates in the digital health and medical device space.

1 investor

Celesta Capital is a venture capital firm that invests in deep tech companies at the forefront of science and engineering, targeting startups enabling mass adoption of emerging technology, improving health outcomes, and transforming large industries.

1 investor